Medtronic Plc Stock Alpha and Beta Analysis

MDT Stock  USD 86.27  0.59  0.69%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Medtronic PLC. It also helps investors analyze the systematic and unsystematic risks associated with investing in Medtronic PLC over a specified time horizon. Remember, high Medtronic PLC's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Medtronic PLC's market risk premium analysis include:
Beta
0.41
Alpha
(0.11)
Risk
1.07
Sharpe Ratio
(0.02)
Expected Return
(0.02)
Please note that although Medtronic PLC alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Medtronic PLC did 0.11  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Medtronic PLC stock's relative risk over its benchmark. Medtronic PLC has a beta of 0.41  . As returns on the market increase, Medtronic PLC's returns are expected to increase less than the market. However, during the bear market, the loss of holding Medtronic PLC is expected to be smaller as well. At this time, Medtronic PLC's Book Value Per Share is comparatively stable compared to the past year. Enterprise Value Over EBITDA is likely to gain to 24.28 in 2024, whereas Tangible Book Value Per Share is likely to drop (6.02) in 2024.

Medtronic PLC Quarterly Cash And Equivalents

1.34 Billion

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Medtronic PLC Backtesting, Medtronic PLC Valuation, Medtronic PLC Correlation, Medtronic PLC Hype Analysis, Medtronic PLC Volatility, Medtronic PLC History and analyze Medtronic PLC Performance.
For more information on how to buy Medtronic Stock please use our How to Invest in Medtronic PLC guide.

Medtronic PLC Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Medtronic PLC market risk premium is the additional return an investor will receive from holding Medtronic PLC long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Medtronic PLC. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Medtronic PLC's performance over market.
α-0.11   β0.41

Medtronic PLC expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Medtronic PLC's Buy-and-hold return. Our buy-and-hold chart shows how Medtronic PLC performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Medtronic PLC Market Price Analysis

Market price analysis indicators help investors to evaluate how Medtronic PLC stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Medtronic PLC shares will generate the highest return on investment. By understating and applying Medtronic PLC stock market price indicators, traders can identify Medtronic PLC position entry and exit signals to maximize returns.

Medtronic PLC Return and Market Media

The median price of Medtronic PLC for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 is 89.06 with a coefficient of variation of 1.85. The daily time series for the period is distributed with a sample standard deviation of 1.65, arithmetic mean of 88.78, and mean deviation of 1.26. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Disposition of 1540 shares by Gary Corona of Medtronic PLC at 80.0 subject to Rule 16b-3
09/13/2024
 
Medtronic PLC dividend paid on 11th of October 2024
10/11/2024
2
Ping An Health and Medtronic Form Strategic Partnership at the China International Import Expo
11/08/2024
3
Needham maintains hold on Medtronic following Q2 results
11/19/2024
4
Porex Welcomes President Janel Wittmayer
11/20/2024
5
Healing People and Planet 3 Things You Need to Know About This Shared Innovation Challenge
11/21/2024
6
Medtronic buys surgical instrument developer Fortimedix
11/22/2024

About Medtronic PLC Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Medtronic or other stocks. Alpha measures the amount that position in Medtronic PLC has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2010 2015 2020 2024 (projected)
Dividend Yield0.01570.02170.03460.0177
Price To Sales Ratio4.24.63.275.85

Medtronic PLC Upcoming Company Events

As portrayed in its financial statements, the presentation of Medtronic PLC's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Medtronic PLC's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Medtronic PLC's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Medtronic PLC. Please utilize our Beneish M Score to check the likelihood of Medtronic PLC's management manipulating its earnings.
20th of February 2024
Upcoming Quarterly Report
View
23rd of May 2024
Next Financial Report
View
31st of January 2024
Next Fiscal Quarter End
View
23rd of May 2024
Next Fiscal Year End
View
31st of October 2023
Last Quarter Report
View
30th of April 2023
Last Financial Announcement
View

Build Portfolio with Medtronic PLC

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Medtronic Stock Analysis

When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.